Medvite Pharmaceuticals (Opc) Private Limited

Founded in 2018 and headquartered in Karnataka, India.

2018 | Bangaluru, Karnataka (India) | Active
Last Updated: February 12, 2025

Medvite Pharmaceuticals (Opc) Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 37.50%
  • Profit Growth 139.69%
  • Ebitda 126.34%
  • Net Worth 167.47%
  • Total Assets 115.16%

About Medvite Pharmaceuticals (Opc)

Medvite Pharmaceuticals (Opc) Private Limited (MPOPL) is a registered startup operating as a Company incorporated in India on 20 March 2018 (Six years and 11 months 6 days old ). Its registered office is in Bangaluru, Karnataka, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Jayashree Sripathy serves as a director at the Company.

Company Details

  • Location

    Bangaluru, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U74999KA2018OPC111377

  • Company No.

    111377

  • Incorporation Date

    20 Mar 2018

  • Date of AGM

    -

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Pharma

Who are the key members and board of directors at Medvite Pharmaceuticals (Opc)?

Board Members (1)

NameDesignationAppointment DateStatus
Jayashree Sripathy Country flag representing In Director 20-Mar-2018Current

Financial Performance of Medvite Pharmaceuticals (Opc).

Medvite Pharmaceuticals (Opc) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.5% increase. The company also saw a substantial improvement in profitability, with a 139.69% increase in profit. The company's net worth Soared by an impressive increase of 167.47%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
37.50%
Revenue from Operations
37.06%
Total Assets
115.16%
Profit or Loss
139.69%
Net Worth
167.47%
EBITDA
126.34%

What is the Ownership and Shareholding Structure of Medvite Pharmaceuticals (Opc)?

Unlock access to Medvite Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Medvite Pharmaceuticals (Opc)?

Unlock and access historical data on people associated with Medvite Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medvite Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medvite Pharmaceuticals (Opc)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Medvite Pharmaceuticals (Opc)

Recent activity within the organization

  • Balance Sheet

    Medvite Pharmaceuticals (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

    31 Mar 2024

  • Director Appointment

    Jayashree Sripathy was appointed as a Director was appointed as a Director on 20 Mar 2018 & has been associated with this company since 6 years 11 months .

    20 Mar 2018

  • Company Incorporation

    Medvite Pharmaceuticals (Opc) Private Limited was registered on 20 Mar 2018 with Roc Bangalore & aged 6 years 11 months as per MCA records.

    20 Mar 2018

Frequently asked questions

  • Medvite Pharmaceuticals (Opc) Private Limited was incorporated on 20 Mar 2018.

  • The authorized share capital of Medvite Pharmaceuticals (Opc) Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 1 director is associated with Medvite Pharmaceuticals (Opc) Private Limited.

    • Jayashree Sripathy
  • As per Ministry of Corporate Affairs (Mca), the registered address of Medvite Pharmaceuticals (Opc) Private Limited is 96 4Th Cross 2Nd Main Vinayaka Layput Bhoopasandra, India, Bengaluru, Karnataka, 560094.

  • The corporate identification number (CIN) of Medvite Pharmaceuticals (Opc) Private Limited is U74999KA2018OPC111377 and the company number is 111377 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Medvite Pharmaceuticals (Opc) Private Limited has risen by 37.50%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Medvite Pharmaceuticals (Opc) Private Limited has experienced an upsurge of 167.47%.

  • The most recent Balance Sheet for Medvite Pharmaceuticals (Opc) Private Limited was filed with the ROC on 31 Mar 2024.